Puma Biotechnology

Puma Biotechnology

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$56,502
$44,814
$75,453
$54,475
Gross Profit
44,027
34,390
52,326
42,302
EBITDA
13,525
-196
20,883
13,454
EBIT
8,425
-2,696
18,226
10,732
Net Income
8,189
-3,753
13,438
8,844
Net Change In Cash
56,502
44,814
75,453
54,475
Free Cash Flow
1,624
15,416
14,455
9,663
Cash
36,537
36,193
29,635
53,525
Basic Shares
52,596
50,845
51,521
50,929

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$228,371
$230,468
$235,637
$228,031
Gross Profit
170,214
166,064
172,955
172,938
EBITDA
53,342
48,076
47,523
21,889
EBIT
42,404
36,552
36,004
12,049
Net Income
31,111
30,278
21,591
2
Net Change In Cash
228,371
230,468
235,637
228,031
Cost of Revenue
3,500
Free Cash Flow
41,731
38,862
14,369
-22,827
Cash
29,635
69,219
84,585
76,201
Basic Shares
50,653
49,100
47,550
44,929

Earnings Calls

QuarterEPS
2026-06-30
$0.16
2026-03-31
-$0.04
2025-12-31
$0.26
2025-09-30
$0.21